Like The Hub?
Join our community.

‘Hugely, hugely detrimental to patients’: Durhane Wong-Rieger on treating rare diseases and the risks of single-payer pharmacare

You can listen to this episode on Acast, Amazon, Apple, and Spotify.
Podcast & Video

Minister of Health Mark Holland speaks about new national pharmacare legislation during a press conference, Ottawa, Feb. 29, 2024. Patrick Doyle/The Canadian Press.

Durhane Wong-Rieger, the president and CEO of the Canadian Organization for Rare Disorders, discusses the challenges that Canadians with rare disorders face in getting access to drugs and the risk that single-payer pharmacare exacerbates them by focusing too much on cost control and too little on the benefits of personalized medicine.

This episode was made possible by the Canadian Life and Health Insurance Association and listeners like you.